Skip to main content

Peer Review reports

From: LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

Original Submission
1 Apr 2023 Submitted Original manuscript
31 Aug 2023 Reviewed Reviewer Report
8 Sep 2023 Reviewed Reviewer Report
13 Oct 2023 Reviewed Reviewer Report - Michael N. Kammer
28 Oct 2023 Author responded Author comments - Ken Arimura
Resubmission - Version 2
28 Oct 2023 Submitted Manuscript version 2
30 Oct 2023 Author responded Author comments - Ken Arimura
Resubmission - Version 3
30 Oct 2023 Submitted Manuscript version 3
Publishing
13 Nov 2023 Editorially accepted
7 Dec 2023 Article published 10.1186/s12885-023-11636-1

You can find further information about peer review here.

Back to article page